Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective cohort study Antoine BessouXavier ColinFeng Wang Original Paper Open access 25 May 2022 Pages: 321 - 333
Live and let live: understanding the temporal drivers and spillovers of life expectancy in Europe for public planning Pilar Gracia-de-RenteríaHugo Ferrer-PérezGeorge Philippidis Original Paper Open access 26 May 2022 Pages: 335 - 347
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation Bent EstlerVolker RudolphDirk Müller Original Paper Open access 27 May 2022 Pages: 349 - 358
Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis Phatcharaphorn ChotnoppharatphattharaVoratima YoodeeUnchalee Permsuwan Original paper 16 June 2022 Pages: 359 - 376
A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway Ellen BusinkDana KendziaChristian Apel Original Paper Open access 18 June 2022 Pages: 377 - 392
A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program Pei WangSheue-Lih ChongNan Luo Original Paper 05 June 2022 Pages: 393 - 398
EQ-5D-5L: a value set for Romania Elena OlariuWael MohammedLuke Vale Original Paper Open access 10 June 2022 Pages: 399 - 412
Do preferences differ based on respondent experience of a health issue and its treatment? A case study using a public health intervention David J. MottLaura TernentLuke Vale Original Paper 18 June 2022 Pages: 413 - 423
Willingness to provide informal care to older adults in Germany: a discrete choice experiment Lea de JongTorben SchmidtKathrin Damm Original Paper Open access 11 June 2022 Pages: 425 - 436
Does health technology assessment compromise access to pharmaceuticals? Melanie BüssgenTom Stargardt Original Paper Open access 16 June 2022 Pages: 437 - 451
Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review Clare ProudfootRaju GautamKeith Tolley Original Paper Open access 05 July 2022 Pages: 453 - 467
Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs: a propensity score matching study using real-world data Marc HöglingerBrigitte WirthKlaus Eichler Original Paper Open access 18 June 2022 Pages: 469 - 478
Making the rules make sense: valuation of constrained resources Jonathan Siverskog Commentary 20 February 2023 Pages: 479 - 481
Reply to: making the rules make sense: valuation of constrained resources Peter Lindgren Reply 17 February 2023 Pages: 483 - 483